Skip to main content
    C

    Connect Biopharma Holdings Ltd (CNTB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.91
    -0.00 (-0.31%)

    Market Cap: $57.24M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(9/13)
    Avg Surprise
    -0.26%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.25
    Range$-0.32 - $-0.19
    5 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.27+7.3%
    60d ago$-0.28+9.3%
    30d ago$-0.26+2.3%
    7d ago$-0.250.0%
    Current$-0.25
    Revenue Consensus
    $5M
    Range$0 - $34M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.12
    Range$-0.38 - $0.12
    5 analysts
    Revenue Consensus
    $41M
    Range$11M - $111M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.12---
    Sep 26EST
    		-$-0.25---
    Jun 26
    Reported Aug 12
    		$-0.27$-0.32+15.63%Beat-17.4%
    Mar 26
    Reported May 12
    		$-0.27$-0.28+4.60%Beat-41.8%
    Dec 25
    Reported Mar 31
    		$-0.27$-0.30+10.00%Beat+35.7%
    Sep 25
    Reported Nov 12
    		$-0.31$-0.23-34.78%Miss-1731.6%
    Jun 25
    Reported Aug 13
    		$-0.23$-0.22-4.55%Miss-210.0%
    Mar 25
    Reported May 15
    		$-0.19$-0.26+26.92%Beat+64.8%
    Dec 24
    Reported Mar 31
    		$-0.42$0.00N/AMiss-179.1%
    Jun 24
    Reported Sep 5
    		$0.02$-0.03+167.49%Beat+102.1%
    Dec 23
    Reported Apr 16
    		$-0.07$-0.03-131.68%Miss+85.2%
    Jun 23
    Reported Sep 12
    		$-0.54N/A+92.20%Beat-12.5%
    Dec 22
    Reported Apr 11
    		$-0.15N/A+95.80%Beat-50066.7%
    Jun 22
    Reported Sep 13
    		$-0.90$-0.21-328.57%Miss-
    Dec 21
    Reported Mar 31
    		$-0.50$-0.52+3.85%Beat-1502.6%
    Jun 21
    Reported Aug 31
    		$-0.48N/A+79.66%Beat-1433.5%
    Dec 20
    Reported Mar 19
    		$-0.00N/AN/ABeat-
    Jun 20
    Reported Jun 30
    		$0.00N/AN/ABeat-
    Dec 19
    Reported Dec 31
    		$-0.03N/AN/ABeat-
    Jun 19
    Reported Jun 30
    		$-0.03N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.81EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-636.00%
    ROE-140.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio2.37xQuick Ratio2.37x
    Trading Statistics
    Beta-0.18Avg Volume9.40M
    52-Week High$3.8252-Week Low$0.85

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.91
    SMA 20$1.01
    SMA 50$1.69
    SMA 200$2.28
    EMA 10$0.94
    EMA 20$1.08
    EMA 50$1.49
    EMA 200$2.04

    MACD

    Line: -0.22Signal: -0.26Hist: 0.03

    ADX

    ADX: 12.7+DI: 23.2-DI: 23.7

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down72.0
    PSAR$1.46

    Bollinger Bands

    Upper Band$1.29
    Lower Band$0.74
    %B Position5374%(Upper)
    Band Width0.30

    RSI (14-Day)

    Neutral
    32.8

    Momentum Oscillators

    Stoch %K5.9
    Stoch %D5.5
    Williams %R-94.6
    ROC (10d)-7.5%
    Momentum-0.07
    CCI (20d)-69.9
    MFI (14d)91.1

    Volatility Measures

    ATR (14d)$0.15(17.0%)
    StdDev (20d)0.14
    Hist Vol89.7%(High)

    Volume Flow

    VWAP$0.90
    OBV149.8M
    AD Line-163.0M
    CMF (20d)-0.817

    Volume Metrics

    Avg Vol (20d)10.1M
    Vol Ratio0.1x(Low)
    VWMA (20d)$1.08

    Pivot Points

    R3$0.99
    R2$0.96
    R1$0.93
    Pivot Point$0.90
    S1$0.88
    S2$0.84
    S3$0.82

    Advanced Oscillators

    TSI-36.57
    Ultimate Osc38.0
    KST-454.35

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.94M$169,000$16,000$16,000$48,000$0$698,000$1.22M$24.12M$12.06M$0N/A
    Cost of RevenueN/AN/AN/AN/AN/AN/A$183,528N/A$476,000$481,873$0N/A
    Gross Profit$2.94MN/A$16,000N/A$48,000N/A$698,000N/A$24.12M$-481,873$0N/A
    Operating Expenses$40.15M$19.78M$15.53M$17.69M$13.47M$11.45M$10.32M$15.06M$10.47M$36.95M$36.95M$16,617
    R&D$16.27M$15.03M$11.28M$11.11M$8.77M$6.63M$6.24M$9.01M$5.35M$26.36M$26.36M$13,259
    SG&A$4.10M$4.75M$4.24M$6.58M$4.70M$4.81M$4.08M$6.06M$5.12M$7.96M$7.96M$0
    Operating Income$-37,211,000$-19,607,000$-15,526,000$-17,677,000$-13,424,000$-11,447,000$-9,619,000$-13,846,000$13.65M$-36,950,000$-36,950,000N/A
    Interest Income$313,000$260,000$384,000$545,000$619,000$720,000$849,000$1.14M$836,000$1.25M$-2,488,068$0
    Interest Expense$0$0$0$0$0$0$20,000$0$20,000$10,388$-10,388$0
    Income Before Tax$-36,574,000$-19,350,000$-15,082,000$-17,139,000$-12,844,000$-10,218,000$-8,800,000$-12,819,000$14.88M$-31,576,000$-31,576,000$0
    Income Tax Expense$108,000$0$27,000$0$55,000$0$106,000$0$30,000$56,000$56,000$0
    Net Income$-36,682,000$-19,398,000$-15,109,000$-17,200,000$-12,899,000$-10,272,000$-8,906,000$-12,876,000$14.85M$-31,632,000$-31,632,000N/A
    EBITDA$-36,886,000$-19,443,000$-14,901,000$-17,498,000$-12,673,000N/A$-8,616,000N/A$15.06M$-35,337,000$-35,337,000$-16,404,525
    EBIT$-37,211,000$-19,607,000$-15,082,000$-17,677,000$-12,844,000N/A$-8,800,000N/A$14.90M$-35,687,000$-35,687,000N/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CNTB

    News

    Connect Biopharma Q3 2026 Earnings Date and Estimates

    Connect Biopharma (CNTB) is projected to announce its Q3 2026 earnings on Wednesday, November 11, 2026, with a conference call scheduled for November 12, 2026...

    MarketBeat•10/15/26•Neutral

    H.C. Wainwright reiterates Buy on Connect Biopharma stock

    H.C. Wainwright has reiterated a Buy rating and a $7.00 price target for Connect Biopharma Holdings Ltd (NASDAQ:CNTB)...

    Investing.com•10/8/26•Bullish

    Connect Biopharma (NASDAQ:CNTB) Stock Rating Reaffirmed as "Buy" by HC Wainwright

    HC Wainwright has reiterated its "buy" rating for Connect Biopharma (NASDAQ:CNTB) and provided detailed earnings estimates through 2030. Other analysts have also issued ratings...

    MarketBeat•10/8/26•Bullish

    Q3 EPS Estimate for Connect Biopharma Reduced by Analyst

    HC Wainwright has lowered its Q3 2026 EPS estimate for Connect Biopharma (NASDAQ:CNTB) to a loss of $0.32 per share, down from $0.30, while maintaining a "Buy" rating. Despite the reduced forecast...

    MarketBeat•10/7/26•Neutral

    A holder reports sole voting power over 400,000 Connect Biopharma (CNTB) shares, plus shared ownership.

    Braden M Leonard and BML Investment Partners, L.P. have filed a Schedule 13G for Connect Biopharma Holdings Ltd (CNTB). Braden M Leonard reports beneficial ownership of 4,264,400 shares (6.77% of the class)...

    Stock Titan•10/6/26•Neutral

    CNTB Valuation and Fair Value

    P/E
    -0.8x
    Forward P/E
    0.8x
    P/B
    2.1x
    See GNG's fair value

    CNTB Profitability: Margins, ROIC and FCF

    Operating margin
    -636.0%
    Net margin
    0.0%
    ROE
    -140.5%
    FCF margin
    -2442.8%

    CNTB Competitors

    CompanyTicker
    Gain Therapeutics IncGANX
    Pheton Holdings Ltd Class A Ordinary SharesPTHL
    Daxor CorporationDXR
    RenovoRx IncRNXT
    Tenax Therapeutics IncTENX
    Talphera Inc.TLPH
    ZEN Graphene Solutions LtdZTEK
    Pliant Therapeutics IncPLRX

    Sector: Healthcare

    CNTB Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    1
    Buy
    7
    Hold
    0
    Sell
    0
    Strong Sell
    0

    CNTB Bull Case vs Bear Case

    Bull case

    • CNTB grew quarterly revenue 5667.0% year over year.
    • 100.0% of CNTB's analyst ratings are Buy or Strong Buy.

    CNTB Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    26.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.25
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 1 down

    Frequently Asked Questions About CNTB

    Does CNTB pay dividends?

    Connect Biopharma Holdings Ltd (CNTB) does not currently pay a regular dividend.

    What is CNTB's market cap?

    Connect Biopharma Holdings Ltd (CNTB) has a market capitalization of $57.24M with a current stock price of $0.91.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In